Humoral Immune Disorders Affect Clinical Outcomes of Oral Lichen Planus.

Maofeng Qing,Dan Yang,Qianhui Shang,Weiqi Li,Yu Zhou,Hao Xu,Qianming Chen
DOI: https://doi.org/10.1111/odi.14667
2024-01-01
Oral Diseases
Abstract:OBJECTIVES:The molecular characteristics of oral lichen planus (OLP) are still unclear, and it is not possible to distinguish the clinical outcome of OLP patients in a short period of time for follow-up. Here, we investigate the molecular characteristics of lesions in patients with stable lichen planus (SOLP) and recalcitrant erosive oral lichen planus (REOLP). METHODS:Our clinical follow-up cohort was split into SOLP and REOLP groups based on the follow-up clinical data. The core modules associated with the clinical information were identified by weighted gene co-expression network analysis (WGCNA). The OLP cohort samples were divided into two groups by molecular typing, and a prediction model for OLP was created by training neural networks with the neuralnet package. RESULTS:We screened 546 genes in five modules. After doing a molecular type of OLP, it was determined that B cells might have a significant impact on the clinical outcome of OLP. In addition, by means of machine learning, a prediction model was developed to predict the clinical regression of OLP with greater accuracy than the existing clinical diagnostic. CONCLUSIONS:Our study revealed humoral immune disorders may make an important contribution to the clinical outcome of OLP.
What problem does this paper attempt to address?